Canakinumab Subcutaneous and Oxymetazoline Hydrochloride
Determining the interaction of Canakinumab Subcutaneous and Oxymetazoline Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: oxymetazoline ophthalmic
Brand name: Visine LR, Visine Long Lasting, Ocuclear
Synonyms: Oxymetazoline ophthalmic, Oxymetazoline (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Oxymetazoline Hydrochloride topical
- Canakinumab Subcutaneous-Oxymetazoline nasal
- Canakinumab Subcutaneous-Oxymetazoline ophthalmic
- Canakinumab Subcutaneous-Oxymetazoline topical
- Canakinumab Subcutaneous-Oxymetazoline Topical application
- Canakinumab Subcutaneous-Oxymetholone
- Oxymetazoline Hydrochloride-Canasa
- Oxymetazoline Hydrochloride-Canasa Pac rectal
- Oxymetazoline Hydrochloride-Canasa rectal
- Oxymetazoline Hydrochloride-Cancidas
- Oxymetazoline Hydrochloride-Candesartan
- Oxymetazoline Hydrochloride-Candesartan and Hydrochlorothiazide